Status: Not yet recruiting
CArdio-Reno- Hepato -MEtabolic Disease iN Chronic Heart Failure (CARMEN-CHF)
Study aims to investigate the incidence, associations and prognostic value of CRGM and its components: chronic kidney disease, type 2 diabetes, atherosclerotic cardiovascular diseases, and non-alcoholic fatty liver disease in patients with different phenotypes and severity of clinical manifestations of CHF.
Participants needed: 3,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Russian Scientific Medical Society of TherapistsUpdated: Feb 2, 2026
Eligibility criteria
Age ≥18 years; [+5]
1. Current participation in a randomized clinical trial; 2. Confirmed or suspect...